Resmed (RMD) Total Non-Current Liabilities (2010 - 2026)

Resmed's Total Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $941.2 million for Q1 2026.

• Quarterly Total Non-Current Liabilities fell 12.87% year-over-year to $941.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $941.2 million (down 12.87% YoY) and the FY2025 annual result came in at $1.2 billion, up 8.17% from the prior year.
• Total Non-Current Liabilities was $941.2 million for Q1 2026 at Resmed, up from $934.4 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $2.2 billion in Q4 2022 and bottomed at $931.6 million in Q3 2025.
• A 5-year average of $1.3 billion and a median of $1.1 billion in 2024 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 127.85% — and 2024, when it slumped 41.09%.
• Resmed's Total Non-Current Liabilities stood at $2.2 billion in 2022, then fell by 24.76% to $1.7 billion in 2023, then tumbled by 37.54% to $1.0 billion in 2024, then fell by 9.84% to $934.4 million in 2025, then grew by 0.73% to $941.2 million in 2026.
• Business Quant data shows RMD's Total Non-Current Liabilities at $941.2 million in Q1 2026, $934.4 million in Q4 2025, and $931.6 million in Q3 2025.